lifestyle.celebhomes.net
Home
Sample Page
Author:
Aytu BioPharma, Inc.
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
May 6, 2026
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
January 27, 2026
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
January 15, 2026
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
January 13, 2026
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
December 20, 2025
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
December 19, 2025